Translational Development Acquisition (TDACW) EBIT Growth (1y) (2025 - 2026)
Analysis
Translational Development Acquisition (TDACW) EBIT Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Jefferies Financial | 11.46 Bn | -3.99 Bn | 3.09 Bn | - |
| 2 | Evercore | 11.05 Bn | 8.65 Bn | 975.67 Mn | -6.78% |
| 3 | Houlihan Lokey | 9.15 Bn | 7.96 Bn | - | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -7.63% |
| 5 | Piper Sandler Companies | 5.17 Bn | 4.87 Bn | - | 99.46% |
| 6 | Moelis | 4.93 Bn | 4.72 Bn | - | 20.12% |
| 7 | PJT Partners | 4.71 Bn | 4.09 Bn | 481.98 Mn | 37.18% |
| 8 | Lazard | 4.32 Bn | 3.22 Bn | - | -59.60% |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | 26.64% |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | -198.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -198.95% |
| Mar 31, 2026 | 19.07% |
| Dec 31, 2025 | -21.71% |
| Sep 30, 2025 | -248.64% |